BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25271736)

  • 1. Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2.
    Kokontis JM; Lin HP; Jiang SS; Lin CY; Fukuchi J; Hiipakka RA; Chung CJ; Chan TM; Liao S; Chang CH; Chuu CP
    PLoS One; 2014; 9(10):e109170. PubMed ID: 25271736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
    Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells.
    Lu L; Schulz H; Wolf DA
    BMC Cell Biol; 2002 Aug; 3():22. PubMed ID: 12188931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.
    Lin HP; Lin CY; Hsiao PH; Wang HD; Jiang SS; Hsu JM; Jim WT; Chen M; Kung HJ; Chuu CP
    PLoS One; 2013; 8(12):e82625. PubMed ID: 24349321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm.
    Yang ES; Burnstein KL
    J Biol Chem; 2003 Nov; 278(47):46862-8. PubMed ID: 12954644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling.
    Huang SH; Tseng JC; Lin CY; Kuo YY; Wang BJ; Kao YH; Muller CJF; Joubert E; Chuu CP
    Phytomedicine; 2019 Nov; 64():153068. PubMed ID: 31419729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer.
    Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC
    J Biomed Sci; 2011 Aug; 18(1):63. PubMed ID: 21859492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronized prostate cancer cells for studying androgen regulated events in cell cycle progression from G1 into S phase.
    Cifuentes E; Croxen R; Menon M; Barrack ER; Reddy GP
    J Cell Physiol; 2003 Jun; 195(3):337-45. PubMed ID: 12704643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.
    Jiang J; Pan Y; Regan KM; Wu C; Zhang X; Tindall DJ; Huang H
    Prostate; 2012 Feb; 72(2):225-32. PubMed ID: 21630295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulatory effect of Skp2 on the expression and transactivation of the androgen receptor in the progression of castration-resistant prostate cancer].
    Song YT; Wu KJ; Wang XY; Na YG; Yin CM
    Zhonghua Nan Ke Xue; 2016 Feb; 22(2):122-7. PubMed ID: 26939395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
    Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
    Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Castration-resistant prostate cancer cells are dependent on the high activity of CDK7.
    Pallasaho S; Gondane A; Kuivalainen A; Girmay S; Moestue S; Loda M; Itkonen HM
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5255-5263. PubMed ID: 36401094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.
    Brown LK; Kanagasabai T; Li G; Celada SI; Rumph JT; Adunyah SE; Stewart LV; Chen Z
    Prostate; 2024 Jun; 84(9):877-887. PubMed ID: 38605532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
    Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
    Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression.
    Taneja SS; Ha S; Garabedian MJ
    J Cell Biochem; 2001; 84(1):188-99. PubMed ID: 11746527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer.
    Byun WS; Jin M; Yu J; Kim WK; Song J; Chung HJ; Jeong LS; Lee SK
    Biochem Pharmacol; 2018 Dec; 158():84-94. PubMed ID: 30292755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.